These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 28826455)

  • 1. The economic burden of tuberculosis in Indonesia.
    Collins D; Hafidz F; Mustikawati D
    Int J Tuberc Lung Dis; 2017 Sep; 21(9):1041-1048. PubMed ID: 28826455
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Catastrophic total costs in tuberculosis-affected households and their determinants since Indonesia's implementation of universal health coverage.
    Fuady A; Houweling TAJ; Mansyur M; Richardus JH
    Infect Dis Poverty; 2018 Jan; 7(1):3. PubMed ID: 29325589
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tuberculosis care strategies and their economic consequences for patients: the missing link to end tuberculosis.
    Getahun B; Wubie M; Dejenu G; Manyazewal T
    Infect Dis Poverty; 2016 Nov; 5(1):93. PubMed ID: 27799063
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of financial support on reducing the incidence of catastrophic costs among tuberculosis-affected households in Indonesia: eight simulated scenarios.
    Fuady A; Houweling TAJ; Mansyur M; Burhan E; Richardus JH
    Infect Dis Poverty; 2019 Feb; 8(1):10. PubMed ID: 30709415
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Costs to Health Services and the Patient of Treating Tuberculosis: A Systematic Literature Review.
    Laurence YV; Griffiths UK; Vassall A
    Pharmacoeconomics; 2015 Sep; 33(9):939-55. PubMed ID: 25939501
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The socioeconomic impact of multidrug resistant tuberculosis on patients: results from Ethiopia, Indonesia and Kazakhstan.
    van den Hof S; Collins D; Hafidz F; Beyene D; Tursynbayeva A; Tiemersma E
    BMC Infect Dis; 2016 Sep; 16(1):470. PubMed ID: 27595779
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cost of multi drug resistance tuberculosis in Germany.
    Diel R; Nienhaus A; Lampenius N; Rüsch-Gerdes S; Richter E
    Respir Med; 2014 Nov; 108(11):1677-87. PubMed ID: 25443398
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Catastrophic costs incurred by tuberculosis affected households from Thailand's first national tuberculosis patient cost survey.
    Youngkong S; Kamolwat P; Wongrot P; Thavorncharoensap M; Chaikledkaew U; Nateniyom S; Pungrassami P; Praditsitthikorn N; Mahasirimongkol S; Jittikoon J; Nishikiori N; Baena IG; Yamanaka T
    Sci Rep; 2024 May; 14(1):11205. PubMed ID: 38755216
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost analysis of different types of tuberculosis patient at tuberculosis centers in Thailand.
    Kamolratanakul P; Hiransuthikul N; Singhadong N; Kasetjaroen Y; Akksilp S; Lertmaharit S
    Southeast Asian J Trop Med Public Health; 2002 Jun; 33(2):321-30. PubMed ID: 12236432
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Economic burden of multidrug-resistant tuberculosis: a multicenter study across Vietnamese regions.
    Nam VX; Nhung NV; Hoa NB; Thuy HTT; Phuong NTM; Anh NT; Anh LTN; Trung VQ; Ha TV; Meeyai A; Thavorncharoensap M; Chaikledkaew U
    Int J Tuberc Lung Dis; 2018 Aug; 22(8):912-917. PubMed ID: 29991401
    [TBL] [Abstract][Full Text] [Related]  

  • 11. First national tuberculosis patient cost survey in Lao People's Democratic Republic: Assessment of the financial burden faced by TB-affected households and the comparisons by drug-resistance and HIV status.
    Chittamany P; Yamanaka T; Suthepmany S; Sorsavanh T; Siphanthong P; Sebert J; Viney K; Vixaysouk T; Nagai M; Seevisay V; Izumi K; Morishita F; Nishikiori N
    PLoS One; 2020; 15(11):e0241862. PubMed ID: 33180777
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost of treatment for multidrug-resistant tuberculosis in South Korea.
    Kang YA; Choi YJ; Cho YJ; Lee SM; Yoo CG; Kim YW; Han SK; Shim YS; Yim JJ
    Respirology; 2006 Nov; 11(6):793-8. PubMed ID: 17052310
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cost-effectiveness of treating multidrug-resistant tuberculosis.
    Resch SC; Salomon JA; Murray M; Weinstein MC
    PLoS Med; 2006 Jul; 3(7):e241. PubMed ID: 16796403
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Estimating the global burden of multidrug-resistant tuberculosis among prevalent cases of tuberculosis.
    Nourzad S; Jenkins HE; Milstein M; Mitnick CD
    Int J Tuberc Lung Dis; 2017 Jan; 21(1):6-11. PubMed ID: 28157458
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The burden of disease, economic costs and clinical consequences of tuberculosis in the Philippines.
    Peabody JW; Shimkhada R; Tan C; Luck J
    Health Policy Plan; 2005 Nov; 20(6):347-53. PubMed ID: 16155066
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modeling the likely economic cost of non-adherence to TB medicines in the Philippines.
    Collins D; Lam H; Firdaus H; Antipolo J; Mangao P
    Int J Tuberc Lung Dis; 2020 Sep; 24(9):902-909. PubMed ID: 33156756
    [No Abstract]   [Full Text] [Related]  

  • 17. Tuberculosis: cost of illness in Germany.
    Diel R; Rutz S; Castell S; Schaberg T
    Eur Respir J; 2012 Jul; 40(1):143-51. PubMed ID: 22267754
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost-comparison of different management policies for tuberculosis patients in Italy. AIPO TB Study Group.
    Migliori GB; Ambrosetti M; Besozzi G; Farris B; Nutini S; Saini L; Casali L; Nardini S; Bugiani M; Neri M; Raviglione MC
    Bull World Health Organ; 1999; 77(6):467-76. PubMed ID: 10427931
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of Health-Related Quality of Life and Incurred Costs Among Human Immunodeficiency Virus, Tuberculosis, and Tuberculosis/HIV Coinfected Outpatients in Indonesia.
    Idrus LR; Fitria N; Purba FD; Alffenaar JC; Postma MJ
    Value Health Reg Issues; 2024 May; 41():32-40. PubMed ID: 38194897
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cost and cost-effectiveness of multidrug-resistant tuberculosis treatment in Estonia and Russia.
    Floyd K; Hutubessy R; Kliiman K; Centis R; Khurieva N; Jakobowiak W; Danilovits M; Peremitin G; Keshavjee S; Migliori GB
    Eur Respir J; 2012 Jul; 40(1):133-42. PubMed ID: 22362862
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.